Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2024 Publisher: Atnahs Pharma UK Limited, Sovereign House, Miles Gray Road, Basildon, Essex, SS14 3FR, United Kingdom
Toradol 30 mg/ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Toradol is a clear, slightly yellow solution for intramuscular or bolus intravenous injection. |
Toradol contains ketorolac trometamol 30 mg in ampoules of 1ml. It also contains ethanol, sodium chloride and water.
Excipient(s) with known effect:
Each ml of Toradol 30mg solution for Injection contains 100 mg of alcohol (ethanol).
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration. |
| List of Excipients |
|---|
|
Ethanol |
Toradol 30 mg is available in single-dose ampoules containing 1 ml of solution in cartons of 1, 5 or 10.
Atnahs Pharma UK Limited, Sovereign House, Miles Gray Road, Basildon, Essex, SS14 3FR, United Kingdom
PL 43252/0009
31 May 1996
| Drug | Countries | |
|---|---|---|
| TORADOL | Brazil, Canada, Spain, Finland, Hong Kong, Italy, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.